biospecimen__admin__batch_number	100.78.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	2768EA01-6367-4EFB-9CC0-72EF954313D3
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EI-11A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EI-11A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EI-11A
biospecimen__bio__biospecimen_barcode_bottom	0108433576
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	01
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	03
biospecimen__bio__plate_column	8
biospecimen__bio__plate_id	A130
biospecimen__bio__plate_row	E
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EI
biospecimen__shared__patient_id	A1EI
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	D37525CF-B284-45DF-B83D-C9FCAA57EC11
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	5.1
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.9
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	24
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__hist_hepato_carcinoma_risk	cirrhosis
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	10.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	46
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EI-F42222
clinical__clin_shared__bcr_followup_uuid	94B7ECA9-3FBF-41E0-B938-1DF33B9A9857
clinical__clin_shared__cancer_first_degree_relative	0
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	2
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__platelet_result_count	148
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2011
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__nte__new_tumor_event_after_initial_treatment	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	8282de88-1b45-47bc-add1-48b99c8b82b9
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EI-11A-11R-A130-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	7115723f-af64-4b96-92c8-c86b82130a9d
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.77
gdc__analytes__analyte_id	283e254c-41aa-439d-b9ce-dd259fed111a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	3acf7438-fd65-442c-8a30-68b6714537f3
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:49:30.029218-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	dfaafadc-03ba-5380-83ca-4a21f7a03254
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1962
gdc__diagnoses__age_at_diagnosis	17097
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-17097.0
gdc__diagnoses__days_to_last_follow_up	183.0
gdc__diagnoses__diagnosis_id	13c9e344-5617-5303-bb5c-10dc72144dc8
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.53061224489796
gdc__exposures__exposure_id	d0df670c-0d78-5151-8898-a2fc06518fc1
gdc__exposures__height	175.0
gdc__exposures__weight	69.0
gdc__file_id	a0bf4b4f-24b5-44a0-bfdf-585004d60743
gdc__file_name	b8aef3cd-383c-455f-918a-cfd7405ef7f5.mirbase21.mirnas.quantification.txt
gdc__file_size	50256
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	309a81f5424d5defd56bbaf7192cfaef
gdc__portions__is_ffpe	false
gdc__portions__portion_id	1c8242ca-fbd4-4c14-944c-4660b651f79b
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	926
gdc__samples__initial_weight	190.0
gdc__samples__oct_embedded	true
gdc__samples__sample_id	48f02d39-0821-4a45-87a1-11349283e105
gdc__samples__sample_type	Solid Tissue Normal
gdc__samples__sample_type_id	11
gdc__slides__percent_lymphocyte_infiltration	10.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	70.0
gdc__slides__percent_stromal_cells	30.0
gdc__slides__percent_tumor_cells	0.0
gdc__slides__percent_tumor_nuclei	0.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	a87e9d5c-c643-4cb6-be09-1dcf58b27a60
gdc__submitter_id	mirna_swap_dr11_389_MirnaExpression4bdd75d8-5592-4e55-a590-ee05bf133eda_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	29c8bab7-c749-525c-bfca-6a78513a2a38
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:09:44.738+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8282de88-1b45-47bc-add1-48b99c8b82b9-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/8282de88-1b45-47bc-add1-48b99c8b82b9-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129627
manually_curated__local_md5	4a94275a67b5bfe5973ffc772e254727
manually_curated__opengdc_download_date	2018-10-16T17:12:14.000421+02:00
manually_curated__opengdc_file_md5	a5a0fa71124af1d6d4201939ef287531
manually_curated__opengdc_file_size	50255
manually_curated__opengdc_id	8282de88-1b45-47bc-add1-48b99c8b82b9-meq
manually_curated__origin_file_size	129627
manually_curated__origin_last_modified_date	Tue Oct 16 17:27:00 CEST 2018
manually_curated__origin_md5	4a94275a67b5bfe5973ffc772e254727
manually_curated__tissue_status	normal
num	1881
